Tags

Type your tag names separated by a space and hit enter

Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group.
Am Heart J. 2005 Aug; 150(2):251-6.AH

Abstract

OBJECTIVE

Nitrate-stimulated tilt testing may be used to diagnose vasovagal syncope or to guide therapy. To date, the reproducibility of the test in patients with clinically suspected vasovagal syncope and healthy controls is undetermined. A high reproducibility is a prerequisite for correct interpretation of the test result. This study investigates the reproducibility of a nitrate-stimulated tilt test in patients with clinically suspected vasovagal syncope and a healthy control group.

METHODS AND RESULTS

We studied 43 patients (24 women, 19 men) with a typical history of vasovagal syncope and 18 healthy controls (3 women, 15 men). We used a combined tilt protocol with a 30-minute passive and 15-minute nitrate-stimulated phase. The second tilt test was performed 16 +/- 12 days after the first. In both patients and controls, overall positive tilt responses were reproduced in the second test in 100%. In contrast to this, the reproducibility of an overall negative test was 50% in patients but 93% in controls. Overall hemodynamic responses to tilt were reproducible in 80%.

CONCLUSION

Nitrate-stimulated tilt testing in both patients with suspected vasovagal syncope and controls has an excellent reproducibility of positive results but a moderate reproducibility of negative results. Importantly, these results are still valid at a repeat interval of 2 weeks and longer. These data suggest that in patients with suspected vasovagal syncope, a nitrate-stimulated tilt test may provide a suitable tool to evaluate the efficacy of a therapeutic approach.

Authors+Show Affiliations

Department of Cardiology, Atrium Medisch Centrum, Heerlen, The Netherlands. AAS02@atriummc.nlNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Evaluation Study
Journal Article

Language

eng

PubMed ID

16086926

Citation

Aerts, Arnaud J J., et al. "Reproducibility of Nitrate-stimulated Tilt Testing in Patients With Suspected Vasovagal Syncope and a Healthy Control Group." American Heart Journal, vol. 150, no. 2, 2005, pp. 251-6.
Aerts AJ, Dendale P, Block P, et al. Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group. Am Heart J. 2005;150(2):251-6.
Aerts, A. J., Dendale, P., Block, P., & Dassen, W. R. (2005). Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group. American Heart Journal, 150(2), 251-6.
Aerts AJ, et al. Reproducibility of Nitrate-stimulated Tilt Testing in Patients With Suspected Vasovagal Syncope and a Healthy Control Group. Am Heart J. 2005;150(2):251-6. PubMed PMID: 16086926.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group. AU - Aerts,Arnaud J J, AU - Dendale,Paul, AU - Block,Pierre, AU - Dassen,Willem R M, PY - 2004/05/11/received PY - 2004/08/01/accepted PY - 2005/8/10/pubmed PY - 2005/12/13/medline PY - 2005/8/10/entrez SP - 251 EP - 6 JF - American heart journal JO - Am Heart J VL - 150 IS - 2 N2 - OBJECTIVE: Nitrate-stimulated tilt testing may be used to diagnose vasovagal syncope or to guide therapy. To date, the reproducibility of the test in patients with clinically suspected vasovagal syncope and healthy controls is undetermined. A high reproducibility is a prerequisite for correct interpretation of the test result. This study investigates the reproducibility of a nitrate-stimulated tilt test in patients with clinically suspected vasovagal syncope and a healthy control group. METHODS AND RESULTS: We studied 43 patients (24 women, 19 men) with a typical history of vasovagal syncope and 18 healthy controls (3 women, 15 men). We used a combined tilt protocol with a 30-minute passive and 15-minute nitrate-stimulated phase. The second tilt test was performed 16 +/- 12 days after the first. In both patients and controls, overall positive tilt responses were reproduced in the second test in 100%. In contrast to this, the reproducibility of an overall negative test was 50% in patients but 93% in controls. Overall hemodynamic responses to tilt were reproducible in 80%. CONCLUSION: Nitrate-stimulated tilt testing in both patients with suspected vasovagal syncope and controls has an excellent reproducibility of positive results but a moderate reproducibility of negative results. Importantly, these results are still valid at a repeat interval of 2 weeks and longer. These data suggest that in patients with suspected vasovagal syncope, a nitrate-stimulated tilt test may provide a suitable tool to evaluate the efficacy of a therapeutic approach. SN - 1097-6744 UR - https://www.unboundmedicine.com/medline/citation/16086926/Reproducibility_of_nitrate_stimulated_tilt_testing_in_patients_with_suspected_vasovagal_syncope_and_a_healthy_control_group_ DB - PRIME DP - Unbound Medicine ER -